Cancer Clinical Trial -CanariaBio-QPT-ORE-005

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5)

Drug

Oregovomab, Paclitaxel, Carboplatin, Placebo

Phase

Phase III

Condition

Ovarian Clear Cell, Primary Peritoneal, Fallopian Tube

Keywords

Antineoplastic Agents, Phytogenic